| Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial J Kubica, P Adamski, M Ostrowska, J Sikora, JM Kubica, WD Sroka, ... European heart journal 37 (3), 245-252, 2016 | 322 | 2016 |
| METoclopramide administration as a strategy to overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS—the METAMORPHOSIS trial J Sikora, P Niezgoda, M Barańska, K Buszko, N Skibińska, W Sroka, ... Thrombosis and haemostasis 118 (12), 2126-2133, 2018 | 52 | 2018 |
| The Adherence Scale in Chronic Diseases (ASCD). The power of knowledge: the key to successful patient—health care provider cooperation K Buszko, K Obońska, P Michalski, A Kosobucka, A Jurek, M Wawrzyniak, ... Medical Research Journal 1 (1), 37-42, 2016 | 51 | 2016 |
| Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina P Niezgoda, J Sikora, M Barańska, A Sikora, K Buszko, E Siemińska, ... Thrombosis and Haemostasis 117 (04), 718-726, 2017 | 45 | 2017 |
| The readiness for hospital discharge of patients after acute myocardial infarction: a new self-reported questionnaire K Buszko, A Kosobucka, P Michalski, Ł Pietrzykowski, A Jurek, ... Medical Research Journal 2 (1), 20-28, 2017 | 36 | 2017 |
| Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A … P Adamski, J Sikora, E Laskowska, K Buszko, M Ostrowska, JM Umińska, ... PLoS One 12 (10), e0186013, 2017 | 33 | 2017 |
| Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled … J Kubica, P Adamski, K Buszko, M Barańska, J Sikora, MP Marszałł, ... European Heart Journal-Cardiovascular Pharmacotherapy 5 (3), 139-148, 2019 | 32 | 2019 |
| Metabolism of ticagrelor in patients with acute coronary syndromes P Adamski, K Buszko, J Sikora, P Niezgoda, M Barańska, M Ostrowska, ... Scientific reports 8 (1), 11746, 2018 | 32 | 2018 |
| Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study J Kubica, P Adamski, K Buszko, A Kubica, W Kuliczkowski, T Fabiszak, ... European Heart Journal–Cardiovascular Pharmacotherapy 4 (3), 152-157, 2018 | 32 | 2018 |
| Hemodynamic response to the head-up tilt test in patients with syncope as a predictor of the test outcome: A meta-analysis approach K Buszko, S Kujawski, JL Newton, P Zalewski Frontiers in physiology 10, 184, 2019 | 28 | 2019 |
| Validation of the Functioning in Chronic Illness Scale (FCIS) K Buszko, Ł Pietrzykowski, P Michalski, A Kosobucka, W Stolarek, ... Medical Research Journal 3 (2), 63-69, 2018 | 28 | 2018 |
| Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor P Adamski, K Buszko, J Sikora, P Niezgoda, T Fabiszak, M Ostrowska, ... Scientific Reports 9 (1), 3924, 2019 | 26 | 2019 |
| SARS-CoV-2—morphology, transmission and diagnosis during pandemic, review with element of meta-analysis K Grudlewska-Buda, N Wiktorczyk-Kapischke, E Wałecka-Zacharska, ... Journal of Clinical Medicine 10 (9), 1962, 2021 | 21 | 2021 |
| Impact of mild therapeutic hypothermia on bioavailability of ticagrelor in patients with acute myocardial infarction after out-of-hospital cardiac arrest JM Umińska, J Ratajczak, K Buszko, P Sobczak, W Sroka, MP Marszałł, ... Cardiology Journal 27 (6), 780-788, 2020 | 21 | 2020 |
| Effectiveness of therapeutic education in patients with myocardial infarction P Michalski, A Kosobucka, Ł Pietrzykowski, M Kasprzak, K Buszko, ... Medical Research Journal 2 (3), 89-96, 2017 | 21 | 2017 |
| Bone morphogenetic protein 6—a possible new player in pathophysiology of heart failure J Banach, W Gilewski, A Słomka, K Buszko, J Błażejewski, D Karasek, ... Clinical and Experimental Pharmacology and Physiology 43 (12), 1247-1250, 2016 | 19 | 2016 |
| Prognostic significance of red cell distribution width and other red cell parameters in patients with chronic heart failure during two years of follow-up Ł Wołowiec, D Rogowicz, J Banach, K Buszko, A Surowiec, J Błażejewski, ... Polish Heart Journal (Kardiologia Polska) 74 (7), 657-664, 2016 | 19 | 2016 |
| Cardiovascular and autonomic responses to whole-body cryostimulation in essential hypertension P Zalewski, K Buszko, M Zawadka-Kunikowska, J Słomko, J Szrajda, ... Cryobiology 69 (2), 249-255, 2014 | 19 | 2014 |
| Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines J Kubica, P Adamski, P Niezgoda, D Alexopoulos, J Badarienė, A Budaj, ... Cardiology journal 27 (6), 661-676, 2020 | 17 | 2020 |
| Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study P Adamski, M Ostrowska, J Sikora, K Obońska, K Buszko, M Krintus, ... BMJ open 7 (4), e013218, 2017 | 17 | 2017 |
